Lokken Investment Group LLC Gilead Sciences, Inc. Transaction History

Lokken Investment Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $3,788 - $4,315	-49 Reduced 1.67%	2,885 $239,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $40,632 - $58,334	-652 Reduced 18.18%	2,934 $251,000
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $94,583 - $118,523	-1,633 Reduced 31.29%	3,586 $213,000
Q4 2021 Feb 07, 2022	BUY	$64.88 - $73.64 $11,094 - $12,592	171 Added 3.39%	5,219 $379,000
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $15,704 - $16,942	-232 Reduced 4.39%	5,048 $353,000
Q2 2021 Aug 03, 2021	BUY	$63.47 - $69.35 $36,939 - $40,361	582 Added 12.39%	5,280 $364,000
Q1 2021 Jun 10, 2021	BUY	$60.0 - $68.46 $2,220 - $2,533	37 Added 0.79%	4,698 $304,000
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $2,096 - $2,388	-37 Reduced 0.79%	4,661 $272,000
Q1 2012 Apr 13, 2021	BUY	N/A	4,698	4,698 $304,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Lokken Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Lokken Investment Group LLC with notifications on news.